The clinical trial for INS115644 (latrunculin B; Inspire Pharmaceuticals) for safety and elevated intraocular pressure in glaucoma was completed September 9, 2009 (clinical trial NCT00443924). No safety issues were found. Read more at http://clinicaltrials.gov/ct2/show/study/NCT00443924?term=INS115644&rank=1.
Natural Products News
Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma
August 11th, 2010Istodax (depsipeptide romidepsin from Chromobacterium violaceum) receives FDA approval
March 24th, 2010The natural product derived Istodax was approved for cutaneous T-cell lymphoma by the US FDA, November 5, 2009.
